SCALING HEALTHCARE IMPACT THROUGH INNOVATION & CAPITAL

Dr Helmut Schuehsler

CEO & Chairman at TVM Capital Healthcare

Dr. Schuehsler is a pioneering investor and operator, shaping the global healthcare landscape. As Chairman & CEO of TVM Capital Healthcare, he has directed over $2B in global healthcare investments, building hospitals and care networks across the Middle East and Asia and establishing himself as one of the foremost voices in healthcare private equity.

Michael Gold

President of Civil and International Space at Redwire

Mike Gold is Redwire's President of Civil and International Space. Prior to joining Redwire, Mike led NASA's Office of International and Interagency Relations and was awarded NASA's Outstanding Leadership Medal for his work on the Artemis Accords.

Sami Yusuf

Chair of Business Development at Mayo Clinic

Dr Sami Yusuf serves as Chair of Corporate Development for International where he is responsible for driving partnerships, strategic collaborations and strategic alliances by coordinating, negotiating, and executing strategic transactions in support of Mayo Clinic and its International business.

Dr Anastasiia Natrova

Advisor (Biotech and Deep Tech) at Family offices (GCC, EU)

Dr Anastasiia Natrova is a medical doctor, neuroscientist, and biotech advisor to investors across the GCC and EU. She connects science, capital, regulation, and strategy to support biotech, longevity, and health innovation globally.

Mr. Lloyd Price

Partner at Nelson Advisors

Lloyd Price is a Partner at Nelson Advisors, one of Europe's leading HealthTech M&A Advisory Firms. Founded and Exited multiple HealthTech companies. Advisor for Oxford MedTech Society, Oxford VC Network and UCL Global Business School for Health.

Dr Yazeed Alsufyani

GP & CEO at IB Ventures

Dr. Yazeed Alsufyani, has led major healthcare funds and built transformative ventures like IV ONE and is launching the Biotech Focused Fund IB Ventures. At GHE, he will explore how scaling capital-backed healthcare models can accelerate Vision 2030 and talk about new investment vehicles supporting healthcare in KSA

Dr. Mussaad Al-Razouki

Operating Partner at Deerfield Management

Dr. Mussaad M. Al-Razouki is an Operating Partner at Deerfield Management and is the Chairman of Société Arabe Des Industries Pharmaceutiques (SAIPH) based in Tunis, Tunisia, Vice Chairman of ACDIMA based in Amman, Jordan

Mr. Christian Hein

Venture Partner & Executive Advisor - Healthtech & AI at Vorwerk Ventures

Christian Hein is a Venture Partner at Vorwerk Ventures. Previously VP of Digital Transformation at Novartis, he's led large scale AI deployments worldwide. He is an Executive Advisor to startups and large life science corporate on scaling AI.

Dr. Mohammad Khobreh

Managing Partner at NG Bio Ltd

Mohammad Khobreh is a biotech investor and entrepreneur leading life sciences investments for a family office. With over 30 investments and major exits, he brings deep expertise in therapeutics, drug discovery, and venture building.

Loretta TIOIELA

Founder and Managing Partner at Next Sequence

Loretta TIOIELA is the Founder & Managing Partner of Next Sequence, a new venture firm focusing on accelerating in companies building at the edge of AI and Biology. She is a technologist with more than 15 years of experience in Cloud and A.I. technologies. She has worked for major industry players such as Samsung Electronics and Huawei Technologies as well as startups.

Mr. Cédric Odje

Senior Associate at Debiopharm Innovation Fund

Cédric Odje is a venture investor and entrepreneur with extensive experience in biotech and oncology innovation. He has supported over 20 startups, serves on several boards, and is passionate about advancing global health and entrepreneurship.

Mr. Antoine D'Hollander

Investment Director at Capricorn Partners

Antoine D'Hollander is the Investment Director of Capricorn Healthtech Fund II. He specializes in investments in European digital and connected medtech companies. With his board representations in these companies, he assists them in navigating and scaling within the challenging healthcare market.

Roberta Marinelli

President and General Manager at Eli Lilly and Company

Roberta Marinelli is an accomplished senior executive with over two decades of international experience in the pharmaceutical and healthcare industries. She currently serves as President and General Manager for Lilly’s META region, based in Dubai.